Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
Ovid Therapeutics Inc. (OVID) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2021 8-K Quarterly results
06/23/2021 8-K Quarterly results
05/18/2021 8-K Quarterly results
04/09/2021 8-K Quarterly results
03/03/2021 8-K Quarterly results
10/22/2020 8-K Investor presentation
Docs: "OV101 (gaboxadol) Teach-In Day Presentation"
06/17/2020 8-K Quarterly results
03/13/2020 8-K Quarterly results
03/02/2020 8-K Quarterly results
09/23/2019 8-K Investor presentation
Docs: "PRODUCT CANDIDATE RESEARCH PRECLINICAL PHASE 1 PHASE 2 PHASE 3 INDICATION",
"Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare Epilepsies Sustained and Progressively-Improving Median Seizure Frequency Reduction Reaching 84-90% with Prolonged Treatment of Soticlestat in this Difficult-to-Treat Patient Population"
06/27/2019 8-K Quarterly results
03/11/2019 8-K Investor presentation
Docs: "Corporate Presentation"
02/19/2019 8-K Quarterly results
01/07/2019 8-K Investor presentation
Docs: "Corporate Presentation, dated January 2019"
12/17/2018 8-K Investor presentation
Docs: "Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies",
"Corporate Presentation"
10/25/2018 8-K Investor presentation
Docs: "Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101 for the Treatment of Angelman Syndrome at the 65 th AACAP Annual Meeting",
"Investor Presentation"
10/01/2018 8-K Quarterly results
08/06/2018 8-K Investor presentation
Docs: "Investor Presentation"
08/15/2017 8-K Investor presentation
Docs: "Corporate Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy